ACC.26丨搶鮮探秘：27項(xiàng)LBCT研究提前看！

POCKETIN

New Orleans

一起探索心血管醫(yī)學(xué)的未來(lái)

北京時(shí)間3月28日至30日，由美國(guó)心臟病學(xué)會(huì)（ACC）舉辦的心血管領(lǐng)域盛會(huì)——ACC.26學(xué)術(shù)會(huì)議將在美國(guó)新奧爾良隆重舉行。本次為期3天的會(huì)議亮點(diǎn)滿(mǎn)滿(mǎn)，設(shè)有7場(chǎng)最新突破性臨床試驗(yàn)（Late-Breaking Clinical Trials），將公布27項(xiàng)前沿臨床研究成果。其中，來(lái)自中國(guó)南京市第一醫(yī)院的陳紹良教授將在壓軸的LBCT VII專(zhuān)場(chǎng)報(bào)告其團(tuán)隊(duì)的重要研究，展現(xiàn)中國(guó)學(xué)者在國(guó)際頂尖學(xué)術(shù)舞臺(tái)上的影響力。

POCKETIN基于各大研究注冊(cè)信息及既往公布的相關(guān)研究文獻(xiàn)，推出“LBCT 搶先看”欄目，請(qǐng)您緊跟我們的步伐，一同踏上這場(chǎng)充滿(mǎn)驚喜與挑戰(zhàn)的ACC.26學(xué)術(shù)之旅。

01

重磅研究，先睹為快

LBCT 搶先看

7場(chǎng)LBCT專(zhuān)場(chǎng)

27項(xiàng)最新研究

跟隨我們

提前探秘ACC.26

解鎖心臟醫(yī)學(xué)新進(jìn)展

02

LBCT日程一覽

Late-Breaking Clinical Trials I

北京時(shí)間：3月28日 23:30-00:30

Ultrasound-Facilitated Catheter-Directed Thrombolysis Vs Anticoagulation Alone For Acute Intermediate-High-Risk Pulmonary Embolism: Primary Results of the HI-PEITHO Randomized Clinical Trial
急性中高危肺栓塞超聲輔助導(dǎo)管導(dǎo)向溶栓 vs. 單純抗凝治療：HI-PEITHO隨機(jī)臨床試驗(yàn)主要結(jié)果
Stavros V. Konstantinides
Outcomes in Patients With Atrial Fibrillation Randomized to Receive Left Atrial Appendage Closure or Oral Anticoagulation: Primary Results of the CHAMPION-AF Clinical Trial
隨機(jī)接受左心耳封堵術(shù)或口服抗凝治療的房顫患者的結(jié)局：CHAMPION-AF臨床試驗(yàn)的主要結(jié)果
Saibal Kar Primary Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardiogenic Shock: Results From the STEMI-Door to Unload Randomized Clinical Trial
無(wú)心源性休克前壁ST段抬高型心肌梗死的早期左心室減負(fù)荷治療：STEMI-Door to Unload隨機(jī)臨床試驗(yàn)結(jié)果
Navin Kapur

Late-Breaking Clinical Trials II

北京時(shí)間：3月29日 5:45-6:45

Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension
KARDINAL研究：評(píng)估Tonlamarsen治療未控制高血壓的2期臨床試驗(yàn)

Luke Laffin

Evolocumab in Patients Without Significant Atherosclerosis: Results From VESALIUS-CV
依洛尤單抗在無(wú)顯著動(dòng)脈粥樣硬化患者中的應(yīng)用：VESALIUS-CV研究結(jié)果
Nicholas Marston Intensive Low-Density Lipoprotein Cholesterol Targeting in Patients With Atherosclerotic Cardiovascular Disease
動(dòng)脈粥樣硬化性心血管疾病患者強(qiáng)化低密度脂蛋白膽固醇目標(biāo)值設(shè)定
Yong-Joon Lee
DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension: Results From the GoFreshRx Randomized Clinical Trial
為經(jīng)治療的高血壓成人提供DASH模式食品以降低血壓：GoFreshRx隨機(jī)臨床試驗(yàn)結(jié)果

Stephen Paul Juraschek

Late-Breaking Clinical Trials III

北京時(shí)間：3月29日 22:30-23:30

Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3)
高危冠狀動(dòng)脈介入治療中經(jīng)皮左心室減負(fù)荷技術(shù)的對(duì)照試驗(yàn)：CHIP-BCIS3研究
Divaka Perera
A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With An Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention
一項(xiàng)大規(guī)模全球隨機(jī)試驗(yàn)：比較基于常規(guī)造影衍生的冠狀動(dòng)脈生理學(xué)與基于有創(chuàng)壓力導(dǎo)絲的方法指導(dǎo)經(jīng)皮冠狀動(dòng)脈介入治療
Ajay J. Kirtane A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina- ORBITA-CTO Trial
穩(wěn)定型心絞痛患者慢性完全閉塞病變經(jīng)皮冠狀動(dòng)脈介入治療的隨機(jī)、安慰劑對(duì)照試驗(yàn)——ORBITA-CTO試驗(yàn)
Sarosh A. Khan
Fractional Flow Reserve or 3d-quantitative Coronary Angiography-Based Vessel-Ffr Guided Revascularization – The Fast Iii Trial
血流儲(chǔ)備分?jǐn)?shù)或基于3D定量冠狀動(dòng)脈造影的血管FFR指導(dǎo)血運(yùn)重建——Fast III試驗(yàn)

Joost Daemen

Late-Breaking Clinical Trials IV

北京時(shí)間：3月30日 00:45-1:45

Spironolactone in the Treatment of Heart Failure
螺內(nèi)酯治療心力衰竭
Frank Edelmann
Efficacy and Safety of Sotatercept in Combined Post- and Pre-Capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From the Phase 2 Cadence Trial
Sotatercept在射血分?jǐn)?shù)保留型心力衰竭相關(guān)的毛細(xì)血管前后混合性肺動(dòng)脈高壓中的療效與安全性：2期Cadence試驗(yàn)結(jié)果

Mardi Gomberg-Maitland

Lung Impedance-Guided Therapy in Heart Failure With Preserved Ejection Fraction: Results of a Randomized Clinical Trial
基于肺阻抗監(jiān)測(cè)指導(dǎo)射血分?jǐn)?shù)保留型心力衰竭治療：一項(xiàng)隨機(jī)臨床試驗(yàn)結(jié)果
Michael Kleiner Shochat
Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM Trial
Mavacamten用于有癥狀的青少年梗阻性肥厚型心肌病患者：來(lái)自3期Scout-HCM試驗(yàn)的結(jié)果
Joseph William Rossano

Late-Breaking Clinical Trials V

北京時(shí)間：3月30日 6:00-7:00

Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial
再次外科手術(shù) vs. 經(jīng)導(dǎo)管瓣中瓣技術(shù)治療二尖瓣生物瓣功能障礙：SURVIV試驗(yàn)

Dimytri Siqueira

Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial

不常規(guī)進(jìn)行經(jīng)皮冠狀動(dòng)脈介入治療的經(jīng)導(dǎo)管主動(dòng)脈瓣植入術(shù)：一項(xiàng)隨機(jī)對(duì)照試驗(yàn)

Michiel Voskuil

Protect The Head To Head Trial: Randomized Comparison of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement
Protect The Head to Head試驗(yàn)：Emboliner栓塞保護(hù)導(dǎo)管與Sentinel腦保護(hù)系統(tǒng)在經(jīng)導(dǎo)管主動(dòng)脈瓣置換術(shù)中的隨機(jī)對(duì)比研究
Adam B. Greenbaum
Two-Year Outcomes After Transcatheter Tricuspid Repair Without Cross-over in the Randomized Tri-fr Trial
Tri-Fr隨機(jī)試驗(yàn)中無(wú)交叉治療的經(jīng)導(dǎo)管三尖瓣修復(fù)術(shù)后兩年結(jié)局
Erwan Donal

Late-Breaking Clinical Trials VI

北京時(shí)間：3月30日 22:30-23:30

Effects Of A Food-is-medicine Intervention On Blood Pressure Among Black And Hispanic Adults With Hypertension In Healthy Food Priority Areas: The Thrive Pilot Trial
“食物即藥物”干預(yù)對(duì)健康食品優(yōu)先區(qū)域中患有高血壓的黑人和西班牙裔成年人血壓的影響：Thrive 初步試驗(yàn)
Oluwabunmi Ogungbe
Digoxin in Rheumatic Heart Disease: A Multi-Center, Randomized, Double Blind, Placebo-controlled Trial
地高辛用于風(fēng)濕性心臟病：一項(xiàng)多中心、隨機(jī)、雙盲、安慰劑對(duì)照試驗(yàn)
Ganesan Karthikeyan Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction
急性心肌梗死后病情穩(wěn)定患者停用β受體阻滯劑治療
Joo-Yong Hahn
Effect of Intensive Triglyceride Lowering With Olezarsen on Progression of Coronary Atherosclerosis: A Coronary Cta Substudy of The Essence-TIMI 73b Randomized Trial
Olezarsen強(qiáng)化降低甘油三酯對(duì)冠狀動(dòng)脈粥樣硬化進(jìn)展的影響：Essence-TIMI 73b隨機(jī)試驗(yàn)的冠狀動(dòng)脈CTA亞組研究
Nicholas Marston

Late-Breaking Clinical Trials VII

北京時(shí)間：3月31日 00:45-1:45

Primary Efficacy and Safety Results From the Phase 3 Sirolimus-Coated Balloon For Infra-inguinal Peripheral Arterial Disease (SirPAD) Trial
西羅莫司涂層球囊治療腹股溝下外周動(dòng)脈疾病的3期SirPAD試驗(yàn)主要療效與安全性結(jié)果
Stefano Barco
Intravascular Ultrasound Guidance For Complex High-Risk Indicated Procedures – The Ivus Chip Trial
血管內(nèi)超聲指導(dǎo)復(fù)雜高危有指征手術(shù)——Ivus Chip試驗(yàn)

Roberto Diletti

Intravascular Ultrasound-Guided Versus Angiography-Guided Percutaneous Coronary Intervention In Unprotected Left Main Coronary Artery Disease – The Optimal Trial
血管內(nèi)超聲引導(dǎo)對(duì)比造影引導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療在無(wú)保護(hù)左主干冠狀動(dòng)脈疾病中的應(yīng)用——Optimal試驗(yàn)
Adrian Banning
Ivus Or Angiography Guidance For PCI in Complex Coronary Bifurcation Lesions
復(fù)雜冠狀動(dòng)脈分叉病變PCI術(shù)中血管內(nèi)超聲或血管造影指導(dǎo)

南京市第一醫(yī)院 陳紹良

更多精彩 敬請(qǐng)期待